Comments

Enliven Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ELVNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Wed May 14th, after the market close

Enliven Therapeutics (ELVN) Forecast

News Earnings Enliven Therapeutics (ELVN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Enliven Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ELVN | Benzinga

Explore Enliven Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ELVN.

Open	$17.07
Close	-
Volume / Avg.	17.53K / 303.48K
Day Range	$16.99 - $17.37
52 Wk Range	13.30 - 30.03
Market Cap	$840.56M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	22.16%
Days to Cover	28.86

Recent News

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.07
Close	-
Volume / Avg.	17.53K / 303.48K
Day Range	$16.99 - $17.37
52 Wk Range	13.30 - 30.03
Market Cap	$840.56M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	22.16%
Days to Cover	28.86

About Enliven Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Enliven Therapeutics (ELVN) stock?

You can purchase shares of Enliven Therapeutics (NASDAQ:ELVN) through any online brokerage.

View our list of the best stock brokerages

Who are Enliven Therapeutics (ELVN) competitors?

Other companies in Enliven Therapeutics’s space includes: Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Enliven Therapeutics (ELVN) stock?

Enliven Therapeutics has a consensus price target of $35.00.

What is the current price for Enliven Therapeutics (ELVN)?

The stock price for Enliven Therapeutics (NASDAQ: ELVN) is $17.13 last updated May 21, 2025 at 11:57 AM EDT.

Does Enliven Therapeutics (ELVN) pay a dividend?

There are no upcoming dividends for Enliven Therapeutics.

When is Enliven Therapeutics (NASDAQ:ELVN) reporting earnings?

Enliven Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Enliven Therapeutics (ELVN) going to split?

There is no upcoming split for Enliven Therapeutics.

What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.